**[미래에셋 제약/바이오 김승민]**
**10/23 Daily**

[https://t.me/bioksm](https://t.me/bioksm)


 **글로벌 바이오/제약**
────────────────────
 [Merck/Moderna 암 백신, 흑색종 사망/재발 위험 42% 감소](https://news.google.com/rss/articles/CBMiygFBVV95cUxPSXhsdlctOU15SmpPZm9IX2gzemJrTWstX0h6cTZwQmotNjBGOXdWOUFLa0Nob3NpSmY3cmFZLTZUSFRDS2xXVVNySTJhdDNlZURUV2lmaFJhSkpiS3RuN09LRGlpM2ttQklLeTVzWDhsVVlLc3pibG5fZE93QWIzZHk3bFo5NnBZUHhNanhBbng2bDBMbGZibTVhLVFmY3I5YlkyNi1OeHdfYmdNWXV1RHYxdVRFUlZRdV85TFNsVVIxcHV1NUV6MUpB?oc=5)

 [Gilead, PepStar 염증질환 치료제 프로그램을 $1.28bn에 인수](https://news.google.com/rss/articles/CBMitgFBVV95cUxOQkJidXpRVE5KbmQ3MV9ZcmhlZGZZY1pNUFdQY2V2a0RVR0lDMTV5MjdxdXFhVG1Xd0RPdzhRbEljSE1zNEt5cDRFcDJGaTZhOTY3Q1JsenRvUE1UMTRqbkZOZEp6UmdGNzdmM09GekRkbDVRNGJmNUtMYmVQbXFpY254bnB4amgyNy1uYkgtT1RROVdZY3hqOFZKemdtOU5mQll1Q2FsY2cxSnRLZEdYMXdVanBoUQ?oc=5)

 [EQT, 분자진단 기업 Qiagen을 $10.8bn에 인수](https://news.google.com/rss/articles/CBMinwFBVV95cUxNVHkyNW5pTXVNT2J0VFpZaGVHcW95Q3lkRWZ0clJYMVdva0M4b3BDUkwzQkNnRk41T2x3M1E1bDlxUUlCYTI5cVFHc093UU5rYndOcGRpa2FjSHBreml6WGJrbHFBSXhmaTB3QUozeDVQRERJMkhpTDFCUy1zZHk0aWIxcEhpdnJjTUd3bERiNmZleEM1enEyQlpuUDNYekE?oc=5)

 [Astrazeneca, Ultomiris FDA로부터 성인 희귀 신장질환 치료제 승인 획득](https://news.google.com/rss/articles/CBMizgFBVV95cUxNUGpqanV4cTNtMHFsWkNwb2lXeUVRTFJWLXZBai03ZXpLTC1HRnR3VkRjTE40UWRwMDljdE5tTHp4NFJFZWZHNHFoOE56UHRqTUJ1c2UtZVpjbmYzQ25zWmNzcFZsSGREYkxwanljelhaZ2NlWGRMYXNyZVVhRnAySVdpWHltcDNfaXVrLS1UYVN2Z0pYZ0UyeWdQSEp6YnJtY3p3T0Z6Xy1ydklxWUR3N2xlYUtGcDcwd0d6b010WDhGaDdxYVBaU3ZnWmVGdw?oc=5)

 [AbbVie 피부질환 치료제 lutikizumab, 임상에서 병변 감소 보여...체중감량 병용 검토](https://news.google.com/rss/articles/CBMi3AFBVV95cUxON21JQ291ZXpadnFuWmV6UENnVDRfMjZjTFhCTGtTeGd3Qjh4M1FZVU5QRVBLWmkyUm8wNEdkdW1lZFotbGRmNlJ1LVNycGRaWHRXWTJ0WlhIQ1NBcFhOMVpqLTlOSkYwdG8wMGtGVTR1SWs0TGdaLXpRT3RpamJ6ZlV5X0lkZGtIMV9mNHB4blhqamJTLTRGbGtRdjRkOGpyTlYxSEtxNDJVLTdqM3drNEg0bFhOZlQ0X0dpcFdiRGVwTVJsN09GQ2JfMmdOLWVwajBlcHhlZUgtSEhH?oc=5)

 [Roche, 매출 전망 상회 but Xolair 시밀러 판매 확대로 주가 하락](https://news.google.com/rss/articles/CBMi2wFBVV95cUxQcnlRMUFVVVJGZ2xRNVFJcEZmYVIwcXlCQXNxVFYtczMyTGtfYVRueHExRVhmckZTX2luOFR6bkdKdzB2U0xVc0lUY2RVMmtnSm56VXA4MEZnVmZ5MDdLV01HdVpOcG5CQW42cU5VQThjV2ppTVVWYU9sTnBxWURYdkFSNWZxOWlUdnR2MWlPQlo2V2E2VXpJclJCc3NXZ0VKUTlQTUpmVHRkSy1yYXpDdl83ZnprNFpkR3ZzbXJBRWo1SDU5NDl6Z2FWQnJRb2xURlRzTXpHVEo2OUk?oc=5)


 **한국 바이오/제약**
────────────────────
 [셀트리온, 美 카이진 자가면역질환 신약 후보물질 'KG013' 도입](https://www.hitnews.co.kr/news/articleView.html?idxno=80107)

 [알지노믹스, 항암 유전자치료제 ‘RZ-001’ 유럽 희귀의약품 지정에 강세](https://news.google.com/rss/articles/CBMiWkFVX3lxTE9fSnRNdEM1UXdQNVBnNkNhaE1qRXRPc25jQ3Npd01uczBNcGpuT1ItY29sVHgwaHNTbHhRaTlraEVqZEJZcFFGN21BeVpjekRFdFpNbzBDajNwdw?oc=5)

 [씨어스, 용인 신공장 개소… 웨어러블 패치 생산능력 '1.6배' 확대](https://thepharmanews.net/article/seers-wearable-patch-smartfactory-mvittuyr)

────────────────────